STAT+: CMS, FDA team up to fast-track reimbursement for breakthrough devices
Federal regulators have announced a new Medicare coverage pathway for innovative medical devices deemed breakthroughs by the FDA. The program aims to speed up reimbursement for these technologies.
Advertisement: Article Inline